TB-500 Side Effects: Incidence Rates Across Trials
A clinical review of TB-500 (thymosin beta-4 active fragment) adverse event rates drawn from human trials, FAERS reports, and post-market literature. prepared by the HealthRX.com Editorial Team.
TB-500: Side Effects
3 source-based articles maintained by the HealthRX.com Editorial Team.
3articles
1topic areas covered
Jul 14, 2025latest review
TB-500: Side Effects library
Showing 3 of 3 clinical reviews.
TB-500 Side Effects: Rare but Serious Adverse Events
A clinical review of rare and serious adverse events linked to TB-500 (thymosin beta-4 active fragment), including oncologic risk, cardiovascular signals, immunologic effects, and what the current evidence actually shows.
TB-500 Side Effects: Withdrawal and Discontinuation Syndrome
A clinical review of TB-500 (thymosin beta-4 active fragment) withdrawal and discontinuation syndrome, adverse events, and what to expect when stopping this research peptide.